Utah Medical Products Inc... (UTMD)
NASDAQ: UTMD
· Real-Time Price · USD
55.74
-1.13 (-1.99%)
At close: Aug 15, 2025, 3:08 PM
Utah Medical Products Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | 3.04M | 2.9M | 3.56M | 3.45M | 3.96M | 4.29M | 3.94M | 4.2M | 4.21M | 4.55M | 4.28M | 4.1M | 3.53M | 4.13M | 4.21M | 3.43M | 3.02M |
Depreciation & Amortization | 721K | n/a | -808K | 693K | 683K | 1.04M | 1.78M | 1.78M | 1.76M | 1.75M | 1.75M | 1.78M | 1.81M | 1.77M | 1.83M | 1.84M | 1.84M |
Stock-Based Compensation | 82K | 72K | 53K | 52K | 79K | 72K | 53K | 50K | 50K | 62K | 38K | 40K | 43K | 43K | 41K | 41K | 41K |
Other Working Capital | 334K | -130K | -968K | -1.2M | 462K | -303K | -86K | -1.36M | 375K | 163K | 1.47M | -892K | -98K | -496K | 756K | -625K | 572K |
Other Non-Cash Items | -9K | -95K | 1.55M | 2K | n/a | -2K | -2K | -20K | 1K | 15K | -5K | 18K | 8K | 32K | 18K | 6K | 7K |
Deferred Income Tax | -209K | 58K | -53K | -161K | -192K | -409K | -147K | -134K | -1K | 8K | -123K | -142K | -144K | 68K | -182K | 230K | -208K |
Change in Working Capital | 838K | n/a | -447K | -1.28M | 749K | 345K | -503K | -962K | 887K | -712K | -346K | -964K | -204K | -1.06M | 78K | -855K | 832K |
Operating Cash Flow | 4.46M | 2.94M | 3.86M | 2.76M | 5.28M | 5.33M | 5.12M | 4.91M | 6.92M | 5.68M | 5.59M | 4.83M | 5.05M | 4.99M | 5.99M | 4.69M | 5.53M |
Capital Expenditures | -184K | -9K | 137K | -115K | -22K | -90K | -186K | -320K | -43K | -38K | -321K | -222K | -237K | -253K | -77K | -212K | -10K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | -226K | -5K | 27K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -184K | -9K | -89K | -115K | 5K | -90K | -186K | -320K | -43K | -38K | -321K | -222K | -237K | -253K | -77K | -212K | -10K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -3.22M | -6.71M | -3.87M | -6.4M | -2.99M | -2.5M | n/a | n/a | n/a | -2.5M | n/a | -2.5M | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -1.02M | -1.04M | -1.05M | -1.08M | -1.09M | -1.07M | -1.07M | -1.07M | -1.07M | -1.05M | -1.05M | -1.06M | n/a | -8.35M | -1.04M | -1.04M | -1.04M |
Other Financial Acitivies | n/a | n/a | n/a | 294K | 96K | n/a | 36K | 60K | 21K | 131K | 20K | 4K | 19K | n/a | 189K | 3K | 89K |
Financial Cash Flow | -4.24M | -7.75M | -4.92M | -7.19M | -3.98M | -1.07M | -1.03M | -1.01M | -1.05M | -920K | -1.03M | -3.55M | 19K | -8.07M | -850K | -1.04M | -949K |
Net Cash Flow | 349K | -5.48M | -767K | -4.59M | 940K | 4.66M | 3.59M | 3.71M | 5.86M | 5.54M | 3.29M | 351K | 4.9M | -3.35M | 4.82M | 3.47M | 4.44M |
Free Cash Flow | 4.28M | 2.93M | 3.99M | 2.65M | 5.25M | 5.24M | 4.93M | 4.59M | 6.87M | 5.64M | 5.27M | 4.61M | 4.81M | 4.73M | 5.91M | 4.48M | 5.52M |